Facebook Linkedin Twitter

Phase I clinical trials (Drug development)

Nutritionist calculating body mass index of woman for obesity treatment in a clinic room.
News & Features

In Potential $2B Deal, AstraZeneca Licenses Oral GLP-1 Agonist for Weight Loss

Malorye Branca -
0
Brain tumour, illustration
News & Features

Midline Gliomas Show Immune Response to Novel Vaccine

Malorye Branca -
0
Fatty Liver Disease, MASLD
News & Features

USC Collaborates With Auransa on Phase I of Novel Liver Cancer Drug

Malorye Branca -
0
woman holding her wrist pain because using smartphone or computer long time. De Quervain's tenosynovitis, Intersection Symptom, Carpal Tunnel Syndrome or Office syndrome concept. To illustrate tendon damage
News & Features

Lilly and Confo Ink Deal around Non-Opioid Pain Candidate

Malorye Branca -
0
Lymphocytes attacking a cancer cell, illustration
News & Features

Syena Launched by MD Anderson and Replay to Develop TCR NK Cell Therapy

Chris Anderson -
0
Artificial DNA and Intelligence
News & Features

Insilico Medicine’s AI-Designed Fibrosis Drug Passes Phase I Hurdle

Jonathan Smith -
0
T Cells Attacking Cancer Cell
News & Features

Gilead to Purchase Remaining Rights to Potential First-in-Class Immunotherapy from Jounce Therapeutics

Chris Anderson -
0
graphic of the number six
News & Features

These Six Biotechs are Winning the Race to Get AI-Designed Drugs to the Clinic

Helen Albert -
0
Picture of patient receiving a dancer drug to represent precision cancer therapies
News & Features

Inhibitor of RET Receptor Tyrosine Kinase Shows Promise Against Multiple Cancers

Helen Albert -
0
Cancer cells on dna stand background. 3d illustration
Molecular Dx

Repare Nets Potential $1.2B Plus Deal with Roche for ATR Inhibitor

Malorye Branca -
0
123Page 1 of 3

Related Content

Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine